Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Fatty acid uptake can be measured using PET and 14-(R,S)-[F]fluoro-6-thia-heptadecanoic acid ([F]FTHA). However, the relatively rapid rate of [F]FTHA metabolism significantly affects kinetic modeling of tissue uptake. Thus, there is a need for accurate chromatographic methods to analyze the unmetabolized [F]FTHA (parent fraction). Here we present a new radiometabolite analysis (RMA) method, with comparison to a previous method for parent fraction analysis, and its use in a test-retest clinical study under fasting and postprandial conditions. We developed a new thin-layer chromatography (TLC) RMA method for analysis of [F]FTHA parent fraction and its radiometabolites from plasma, by testing stationary phases and eluent combinations. Next, we analyzed [F]FTHA, its radiometabolites, and plasma radioactivity from subjects participating in a clinical study. A total of 17 obese or overweight participants were dosed with [F]FTHA twice under fasting, and twice under postprandial conditions and plasma samples were obtained between 14 min (mean of first sample) and 72 min (mean of last sample) post-injection. Aliquots of 70 plasma samples were analyzed using both methods, enabling head-to-head comparisons. We performed test-retest and group comparisons of the parent fraction and plasma radioactivity.
Results: The new TLC method separated seven [F]FTHA radiometabolite peaks, while the previous method separated three. The new method revealed at least one radiometabolite that was not previously separable from [F]FTHA. From the plasma samples, the mean parent fraction value was on average 7.2 percentage points lower with the new method, compared to the previous method. Repeated [F]FTHA investigations on the same subject revealed reproducible plasma SUV and parent fractions, with different kinetics between the fasted and postprandial conditions.
Conclusions: The newly developed improved radio-TLC method for [F]FTHA RMA enables accurate parent fraction correction, which is required to obtain quantitative data for modelling [F]FTHA PET data. Our test-retest study of fasted and postprandial conditions showed robust reproducibility, and revealed clear differences in the [F]FTHA metabolic rate under different study settings.
Trial Registration: EudraCT No: 2020-005211-48, 04Feb2021; and Clinical Trials registry NCT05132335, 29Oct2021, URL: https://classic.
Clinicaltrials: gov/ct2/show/NCT05132335 .
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11176130 | PMC |
| http://dx.doi.org/10.1186/s13550-024-01114-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluation of Polymer-Based Dust Palliatives in Soil and Stormwater Runoff in an Arid Environment.
Arch Environ Contam Toxicol
September 2025
PolyAnalytik, Inc., London, ON, Canada.
Dust palliatives are used to reduce fugitive dust in areas susceptible to erosion by wind and rain. In 2015, the Bureau of Land Management (BLM) temporarily approved the use of polymer-based dust palliatives during the construction and operation of a solar energy facility and, in 2019, on a mining access road in Clark County, Nevada. The areas treated with palliative are habitat to the desert tortoise.
View Article and Find Full Text PDFToward Imaging of the GABA Transporter Type 1 In Vivo: Quantitative Evaluation of 4 Novel PET Radiotracers in Nonhuman Primates.
J Nucl Med
September 2025
PET Center, Department of Radiology and Biomedical Imaging, Yale University, New Haven, Connecticut.
The main inhibitory neurotransmitter in the central nervous system is γ-aminobutyric acid (GABA). GABA transporter type 1 (GAT-1) is the principal GABA transporter in the brain, and it plays a crucial role in modulating GABA signaling. Its potential role in several neuropsychiatric disorders makes it an important target to study.
View Article and Find Full Text PDFVericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial.
Lancet
August 2025
Université de Lorraine, Inserm CIC 1433, CHRU, Nancy, France.
Background: Vericiguat is indicated to reduce the risk of cardiovascular death and hospitalisation for heart failure in patients with heart failure and reduced ejection fraction (HFrEF) following a recent worsening event. The aim of the VICTOR trial was to assess the effect of vericiguat in patients with HFrEF without recent heart failure worsening.
Methods: In this double-blind, placebo-controlled, phase 3 trial, conducted at 482 sites across 36 countries, patients aged 18 years or older with HFrEF (left ventricular ejection fraction of ≤40%) without heart failure hospitalisation within 6 months or outpatient intravenous diuretic use within 3 months before randomisation were randomly assigned (1:1) using an intervention randomisation system with interactive response technology to oral vericiguat (target 10 mg dose) or matching placebo.
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials.
Lancet
August 2025
Canadian VIGOUR Centre, University of Alberta, Edmonton, AB, Canada.
Background: Following completion of the VICTORIA trial, vericiguat was approved for the treatment of worsening heart failure with reduced ejection fraction (HFrEF) and received a class IIb recommendation in European and North American guidelines. The subsequent VICTOR trial evaluated the use of vericiguat in patients with HFrEF and no recent worsening. We aimed to assess the effect of vericiguat on clinical endpoints through pooled analyses of patient-level data from the VICTORIA and VICTOR trials.
View Article and Find Full Text PDFInvestigating pesticide contamination in arable soils: An advanced monitoring study from Northern Germany.
Sci Total Environ
September 2025
Department of Hydrology and Water Resources Management, Kiel University, Olshausenstraße 75, 24118 Kiel, Germany.
Pesticide contamination in agricultural soils remains a critical environmental issue due to the persistence and mobility of parent compounds and transformation products (TPs). Most studies have focused on surface soils and short-term dynamics, overlooking the long-term transport of pesticides in the subsurface. This study investigates spatiotemporal contamination patterns of applied and non-applied pesticides and their TPs across soil depths at two agricultural sites adjacent to lentic small water bodies (LSWBs) in Northern Germany.
View Article and Find Full Text PDF